MedInvest is hosting a Biotech and Pharma Investor Conference September 18-19, 2024 in New York City. NIH’s Steve Ferguson and Michael Salgaller will be speaking. They will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions! This is a great opportunity to hear from experts on technology transfer at the NIH. Both Salgaller and Ferguson have an in-depth knowledge of how the licensing and collaboration process works as well as information on the available technologies from all NIH institutes and centers.

Ferguson is a Special Advisor at OTT and brings 30+ years of experience on how to set up successful partnerships with NIH and utilize a variety of available opportunities for your own company. Salgaller leads the Technology Analysis and Marketing Unit (TAMU) within the Technology Transfer Center at the National Cancer Institute (NCI) . He has over 20 years of scientific and investment experience and is ready to help foster licensing and collaboration activities between your organization and NCI. Their presentation will focus on patenting, facilitating collaborations, and licensing and technology analysis and marketing.

Registration is through the MedInvest Conferences website. The webinar will be held in person and feature 40+ presenting companies, 6-8 keynotes and panels, and one-on-one meetings.

In the meantime, take a look at the available technologies for licensing or collaboration from the NIH.